User profiles for Iksung Cho
 | Iksung ChoSeverance Cardiovascular Hospital, Yonsei University College of Medicine Verified email at yuhs.ac Cited by 3707 |
[HTML][HTML] Safety and efficacy of NVX-CoV2373 Covid-19 vaccine
…, J Turner, ME Viljoen, G Albert, I Cho… - … England Journal of …, 2021 - Mass Medical Soc
Background Early clinical data from studies of the NVX-CoV2373 vaccine (Novavax), a
recombinant nanoparticle vaccine against severe acute respiratory syndrome coronavirus 2 (…
recombinant nanoparticle vaccine against severe acute respiratory syndrome coronavirus 2 (…
[HTML][HTML] Efficacy and safety of NVX-CoV2373 in adults in the United States and Mexico
Background NVX-CoV2373 is an adjuvanted, recombinant spike protein nanoparticle vaccine
that was shown to have clinical efficacy for the prevention of coronavirus disease 2019 (…
that was shown to have clinical efficacy for the prevention of coronavirus disease 2019 (…
[HTML][HTML] Efficacy of NVX-CoV2373 Covid-19 vaccine against the B. 1.351 variant
…, JS Plested, A Robertson, S Neal, I Cho… - … England Journal of …, 2021 - Mass Medical Soc
Background The emergence of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)
variants threatens progress toward control of the coronavirus disease 2019 (Covid-19) …
variants threatens progress toward control of the coronavirus disease 2019 (Covid-19) …
[HTML][HTML] Phase 1–2 trial of a SARS-CoV-2 recombinant spike protein nanoparticle vaccine
C Keech, G Albert, I Cho, A Robertson… - New england journal …, 2020 - Mass Medical Soc
Background NVX-CoV2373 is a recombinant severe acute respiratory syndrome coronavirus
2 (rSARS-CoV-2) nanoparticle vaccine composed of trimeric full-length SARS-CoV-2 spike …
2 (rSARS-CoV-2) nanoparticle vaccine composed of trimeric full-length SARS-CoV-2 spike …
Efficacy of vaccination with live attenuated, cold-adapted, trivalent, intranasal influenza virus vaccine against a variant (A/Sydney) not contained in the vaccine
RB Belshe, WC Gruber, PM Mendelman, I Cho… - The Journal of …, 2000 - Elsevier
Objective: To determine the safety, immunogenicity, and efficacy of revaccination of children
with live attenuated influenza vaccine. Study design: A 2-year multicenter, double-blind, …
with live attenuated influenza vaccine. Study design: A 2-year multicenter, double-blind, …
Coronary atherosclerotic precursors of acute coronary syndromes
Background : The association of atherosclerotic features with first acute coronary syndromes
(ACS) has not accounted for plaque burden. Objectives : The purpose of this study was to …
(ACS) has not accounted for plaque burden. Objectives : The purpose of this study was to …
[HTML][HTML] Respiratory syncytial virus vaccination during pregnancy and effects in infants
…, AH Baqui, A Calvert, J Chen, I Cho… - … England Journal of …, 2020 - Mass Medical Soc
Background Respiratory syncytial virus (RSV) is the dominant cause of severe lower respiratory
tract infection in infants, with the most severe cases concentrated among younger infants…
tract infection in infants, with the most severe cases concentrated among younger infants…
Safety, immunogenicity, and efficacy of a COVID-19 vaccine (NVX-CoV2373) co-administered with seasonal influenza vaccines: an exploratory substudy of a …
…, J Edelman, F Burns, AM Minassian, I Cho… - The Lancet …, 2022 - thelancet.com
Background The safety and immunogenicity profile of COVID-19 vaccines when administered
concomitantly with seasonal influenza vaccines have not yet been reported. We therefore …
concomitantly with seasonal influenza vaccines have not yet been reported. We therefore …
Atherosclerotic plaque characteristics by CT angiography identify coronary lesions that cause ischemia: a direct comparison to fractional flow reserve
Objectives : This study evaluated the association between atherosclerotic plaque characteristics
(APCs) by coronary computed tomographic angiography (CTA), and lesion ischemia by …
(APCs) by coronary computed tomographic angiography (CTA), and lesion ischemia by …
Coronary computed tomographic angiography and risk of all-cause mortality and nonfatal myocardial infarction in subjects without chest pain syndrome from the …
Background— The predictive value of coronary computed tomographic angiography (cCTA)
in subjects without chest pain syndrome (CPS) has not been established. We investigated …
in subjects without chest pain syndrome (CPS) has not been established. We investigated …